Evidence map›Paper›PMID 31139973›Full record

ArticleAnnals of biomedical engineering2019

Sustained Release of Hydrogen Sulfide (H

Anh-Vu Do, Rasheid Smith, Phillip Tobias, Daniel Carlsen, Erica Pham, Ned B Bowden, Aliasger K Salem

Abstract read
In one paragraph

Article in Annals of biomedical engineering, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anh-Vu DoDivision of Pharmaceutics and Translational Therapeutics, College of Pharmacy, University of Iowa, Iowa, IA, USA.
Rasheid SmithDivision of Pharmaceutics and Translational Therapeutics, College of Pharmacy, University of Iowa, Iowa, IA, USA.
Phillip TobiasDivision of Pharmaceutics and Translational Therapeutics, College of Pharmacy, University of Iowa, Iowa, IA, USA.
Daniel CarlsenDivision of Pharmaceutics and Translational Therapeutics, College of Pharmacy, University of Iowa, Iowa, IA, USA.
Erica PhamDivision of Pharmaceutics and Translational Therapeutics, College of Pharmacy, University of Iowa, Iowa, IA, USA.
Ned B BowdenDepartment of Chemistry, College of Liberal Arts and Sciences, University of Iowa, Iowa, IA, USA.
Aliasger K SalemDivision of Pharmaceutics and Translational Therapeutics, College of Pharmacy, University of Iowa, Iowa, IA, USA. aliasger-salem@uiowa.edu.ORCID http://orcid.org/0000-0002-1923-6633

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Christopher K Laubenthal · 2000 to 2026
$70.0M
Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Jong Sung Kim · 1990 to 2026
$40.5M
National Institutes of Health 5P30CA086862NCI NIH HHS P30 CA086862NIEHS NIH HHS P30 ES005605
6 · The paper itself

Abstract

Hydrogen sulfide (H

Indexed as

BenzamidesDelayed-Action PreparationsDrug CarriersHEK293 CellsHumansHydrogen SulfideOxidative StressPolyestersBenzamidesDelayed-Action PreparationsDrug CarriersHydrogen SulfidePolyesterspoly(lactide)AntioxidantControlled drug releaseHydrogen sulfideReactive oxygen species

Identifiers

PMID31139973
PMCPMC6650332

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.